Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENTRECTINIB Cause Joint effusion? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Joint effusion have been filed in association with ENTRECTINIB (Rozlytrek). This represents 0.3% of all adverse event reports for ENTRECTINIB.

5
Reports of Joint effusion with ENTRECTINIB
0.3%
of all ENTRECTINIB reports
0
Deaths
1
Hospitalizations

How Dangerous Is Joint effusion From ENTRECTINIB?

Of the 5 reports, 1 (20.0%) required hospitalization.

Is Joint effusion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENTRECTINIB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ENTRECTINIB Cause?

Dizziness (143) Off label use (137) Death (126) Disease progression (105) Taste disorder (68) No adverse event (65) Constipation (60) Fatigue (60) Drug ineffective (58) Blood creatinine increased (57)

What Other Drugs Cause Joint effusion?

ADALIMUMAB (1,367) METHOTREXATE (917) ETANERCEPT (826) TOFACITINIB (520) LEFLUNOMIDE (407) TOCILIZUMAB (391) HYDROXYCHLOROQUINE (380) INFLIXIMAB (372) RITUXIMAB (368) PREDNISONE (357)

Which ENTRECTINIB Alternatives Have Lower Joint effusion Risk?

ENTRECTINIB vs ENZALUTAMIDE ENTRECTINIB vs EPCORITAMAB ENTRECTINIB vs EPCORITAMAB-BYSP ENTRECTINIB vs EPERISONE ENTRECTINIB vs EPHEDRINE

Related Pages

ENTRECTINIB Full Profile All Joint effusion Reports All Drugs Causing Joint effusion ENTRECTINIB Demographics